- In a study of 51 people with secondary progressive MS, the antioxidant lipoic acid was shown to reduce the rate of brain tissue loss compared to placebo. Walking improved, but not significantly.
- Safety issues included stomach upset and two cases of kidney dysfunction.
- The researchers are planning a larger, phase 2 clinical trial to further evaluate whether lipoic acid is a safe and effective treatment for progressive MS.
- The team (Rebecca Spain, MD, MSPH, Oregon Health & Science University, and colleagues) report their findings in Neurology & Neuroinflammation,…
Potrebbe interessarti anche